People diagnosed with heart disease can live anywhere from a few months to several decades longer, depending on the specific condition, its severity, and how aggressively it is treated. A 60-year-old man who has survived a heart attack loses roughly 9 years of life expectancy, while the same man diagnosed with congestive heart failure loses about 16 years, according to a European demographic analysis.1European Heart Journal. A cardiovascular life history Those are averages, though, and averages in heart disease can be misleading. The range of outcomes is enormous, shaped by which arteries are blocked, how well the heart still pumps, what other conditions you carry, and whether you have access to modern therapies. The honest answer is that heart disease is not one disease, and the timeline is not one timeline.
Which Type of Heart Disease Matters Most
“Heart disease” is an umbrella that covers coronary artery disease, heart failure, arrhythmias like atrial fibrillation, valvular disease, and congenital defects. Each carries a different prognosis, and lumping them together hides the variation that actually matters to you. Coronary artery disease, the classic “clogged arteries” condition, is the most common form and the leading killer, but its survival curve has improved dramatically with stents, bypass surgery, and modern medications. Heart failure, where the heart can no longer pump effectively, tends to carry a worse prognosis, with roughly half of patients surviving to five years in some registries.2Polish Archives of Internal Medicine. Heart failure with reduced, mildly reduced, and preserved ejection fraction: outcomes and predictors of prognosis Atrial fibrillation, the most common sustained heart rhythm disorder, does not kill as directly but raises mortality substantially through its complications and the conditions that travel with it.
The same European life-expectancy study that pegged heart attack at 9 lost years found that stroke costs a 60-year-old man about 12 years and heart failure about 16. For women, the reductions were even steeper: about 13 years after a heart attack, 15 after a stroke, and 16 with heart failure.1European Heart Journal. A cardiovascular life history These figures give a rough sense of the hierarchy, but they reflect population averages and do not account for modern treatments that have improved since the data were collected.
Coronary Artery Disease and How Many Arteries Are Blocked
If you have coronary artery disease, one of the single biggest predictors of how long you will live is how many of your coronary arteries are significantly narrowed. A landmark 15-year follow-up study found that patients with just one blocked artery had a 48% survival rate at 15 years, compared with 28% for two-vessel disease, 18% for three-vessel disease, and just 9% for left main artery disease.3PubMed. Fifteen year survival study of patients with obstructive coronary artery disease That study was conducted before many modern treatments existed, but the pattern still holds: more blockages mean more risk.
More recent imaging-based research using CT angiography confirmed the gradient. Compared with people who had clean arteries, the death risk rose in a stepwise fashion with each additional vessel affected, reaching about two and a half times higher for three-vessel obstructive disease.4PubMed. Mortality incidence and the severity of coronary atherosclerosis assessed by computed tomography angiography A Danish registry study found a similar pattern after heart attacks: patients with left main or three-vessel disease faced roughly four times the risk of a cardiovascular event in the first year, and the elevated risk persisted even years later, though it shrank over time.5PubMed Central. Coronary artery disease severity and long-term cardiovascular risk in patients with myocardial infarction: a Danish nationwide register-based cohort study
The practical upshot: if your cardiologist tells you that you have single-vessel disease, your long-term outlook is meaningfully different from someone with diffuse multi-vessel blockages. That distinction matters more than most people realize when they hear the generic phrase “heart disease.”
Heart Failure and Ejection Fraction
Heart failure is among the most serious forms of heart disease, and survival numbers reflect it. A Polish cohort study reported one-year survival rates of about 81% to 84% across different heart failure types, but by five years those numbers dropped sharply: roughly 47% survived with reduced pumping function, and about 59% to 61% survived with mildly reduced or preserved pumping function.2Polish Archives of Internal Medicine. Heart failure with reduced, mildly reduced, and preserved ejection fraction: outcomes and predictors of prognosis That means roughly half of heart failure patients with the weakest hearts were dead within five years.
You might expect that patients whose hearts still squeeze relatively well would do dramatically better. The reality is murkier. A large registry-based analysis found that after adjusting for other risk factors, five-year mortality was statistically similar across all ejection fraction categories, hovering around 75%.6PubMed. Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes The discrepancy between studies comes down to patient populations and how you account for age and other conditions. But the takeaway is sobering either way: heart failure remains a serious diagnosis regardless of which subtype you have. The idea that “preserved” heart function means “mild” heart failure is one of the more dangerous misconceptions patients carry.
How Bypass Surgery and Stents Change the Timeline
For people with significant coronary blockages, revascularization, either bypass surgery or stent placement, can extend life substantially. The question of which procedure works better has been studied for decades, and the answer depends on how extensive the disease is.
In patients with multi-vessel disease, bypass surgery consistently shows a survival edge over stents over the long haul. One large study matching over 8,000 patients found that bypass recipients had a 29% lower overall risk of death compared to those who received drug-coated stents, with the survival gap widening over time: by five years, the difference was nearly 7 percentage points.7PubMed Central. Long-Term Mortality of Coronary Artery Bypass Graft Surgery and Stenting with Drug-Eluting Stents Another analysis focusing on three-vessel disease with involvement of a critical artery found that bypass patients had about a 36% lower long-term death risk than stent patients.8PubMed. Long-term outcomes of coronary-artery bypass grafting versus stent implantation
That said, for less complex disease the two strategies produce comparable results. A meta-analysis pooling patient-level data from four major trials found that at five years, the combined rate of death, heart attack, and stroke was essentially identical between stent and bypass groups.9PubMed. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease So if your disease is limited and you are offered a stent, your long-term survival is not being compromised.
Implantable Devices for Sudden Cardiac Death
For patients whose weakened hearts put them at risk of fatal rhythm disturbances, implantable defibrillators (ICDs) can add years by delivering a life-saving shock when the heart goes haywire. A massive real-world study of nearly 186,000 ICD recipients found one-year survival of 92% and five-year survival of 68%.10PubMed. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study For patients who also received a combined device that resynchronizes the heart’s pumping (CRT-D), five-year survival was lower at 54%, reflecting the fact that those patients typically start with more advanced disease.
Multiple trials have confirmed that ICDs improve survival in people with systolic heart failure and those who have been resuscitated from dangerous arrhythmias.11PubMed. Defibrillators: Selecting the Right Device for the Right Patient The addition of defibrillator function to cardiac resynchronization therapy specifically improved long-term survival in patients with milder heart failure symptoms compared to pacing alone.12PubMed. Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy These devices do not cure the underlying disease, but they prevent the most catastrophic outcome, sudden death from an electrical malfunction.
When the Heart Fails Completely
For people with end-stage heart failure who are running out of options, heart transplantation and mechanical heart pumps represent the last frontier. A systematic review comparing transplantation with left ventricular assist devices (LVADs) found no significant difference in one-year mortality between the two strategies, whether the pump was used as a bridge to transplant or as a permanent solution.13PubMed Central. Heart transplantation versus left ventricular assist devices as destination therapy or bridge to transplantation for 1-year mortality: a systematic review and meta-analysis
Newer-generation pumps have pushed these numbers further. A comparison of the HeartMate 3 device with transplant found three-year survival rates of roughly 84% for the pump and 87% for transplant, a gap that was not statistically meaningful.14PubMed. Comparing 3-year survival and readmissions between HeartMate 3 and heart transplant as primary treatment for advanced heart failure Patients did, however, end up in the hospital more often with the pump. For patients supported on earlier-generation devices long term, a registry tracking outcomes through seven years reported a 51% survival rate, with some patients living on their original device for nearly a decade.15PubMed. Long-Term Survival of Patients With Advanced Heart Failure Receiving an Left Ventricular Assist Device Intended as a Bridge to Transplantation The technology keeps improving, and for someone who would otherwise die within months, a pump or transplant can reset the clock by years.
Atrial Fibrillation and Its “Bad Company”
Atrial fibrillation, the irregular heart rhythm that affects tens of millions of people worldwide, occupies an unusual place in this discussion. It raises mortality risk substantially, but researchers have long debated how much of that risk comes from the rhythm itself versus the conditions that tend to accompany it: high blood pressure, diabetes, heart failure, and obesity. One review characterized this as the mortality risk from the “bad company” atrial fibrillation keeps.16PubMed Central. How does Chronic Atrial Fibrillation Influence Mortality in the Modern Treatment Era?
The numbers, though, are hard to dismiss. Large community-based studies have shown that mortality rates in people who develop atrial fibrillation run roughly 50% to 120% higher than in people without it, even after controlling for demographic and clinical factors. The risk increase has been consistently larger in women than in men.17PubMed Central. Mortality in atrial fibrillation. Is it changing? How much of your remaining life you spend in atrial fibrillation also depends on what other conditions you carry. A study estimating life expectancy with and without the condition found that a 55-year-old man with no other cardiometabolic diseases could expect to live about 22 more years, spending roughly 6 of those years with atrial fibrillation. A man the same age carrying two or more cardiometabolic conditions had about 16 years left, with nearly 6 of those in atrial fibrillation.18European Journal of Preventive Cardiology. Burden of cardiometabolic diseases and life expectancy with and without atrial fibrillation among men and women
What You Do After Diagnosis Changes the Odds
Some of the most striking survival data in cardiology come not from drugs or devices but from cardiac rehabilitation, the structured exercise and education programs prescribed after a heart event. Among patients who had undergone a coronary stent procedure, those who participated in cardiac rehab had about a 45% to 47% lower risk of dying from any cause compared with those who skipped it.19PubMed. Impact of cardiac rehabilitation on mortality and cardiovascular events after percutaneous coronary intervention in the community A large Dutch study of cardiovascular patients more broadly found a 32% reduction in all-cause mortality associated with rehab participation, and the benefit held across men and women, younger and older patients, and different socioeconomic backgrounds.20JAMA Network Open. Association of Cardiac Rehabilitation With All-Cause Mortality Among Patients With Cardiovascular Disease in the Netherlands
Diet plays a parallel role. The Mediterranean dietary pattern, heavy on vegetables, olive oil, fish, and whole grains, has been one of the most consistently studied interventions in secondary prevention. A key trial showed that cardiovascular events and deaths dropped significantly for up to four years when heart attack survivors adopted a Mediterranean-style diet.21PubMed Central. The Mediterranean Diet, its Components, and Cardiovascular Disease Broader reviews confirm that closer adherence to this pattern is associated with meaningful reductions in coronary heart disease, stroke, and overall cardiovascular disease.22PubMed. The Mediterranean Diet and Cardiovascular Health
Smoking cessation is probably the single most powerful modifiable factor. In a cohort study of cardiovascular disease patients, the risk of dying from heart-related causes gradually fell toward the level of never-smokers the longer a person stayed quit, with substantial convergence by 20 years after stopping.23Frontiers in Cardiovascular Medicine. Association Between Initiation, Intensity, and Cessation of Smoking and Mortality Risk in Patients With Cardiovascular Disease: A Cohort Study The earlier you quit, the more years you reclaim.
Diabetes, Depression, and the Conditions That Pile On
Heart disease rarely travels alone. Diabetes is one of the most common and dangerous companions. A Korean national cohort found that people with diabetes alone had about 1.7 times the death rate of people without it, but those carrying both diabetes and a heart attack had roughly 3.6 times the rate. Adding stroke on top of that pushed the risk to nearly five times baseline.24The Journal of Clinical Endocrinology & Metabolism. Cardiovascular Diseases and Life Expectancy in Adults With Type 2 Diabetes: A Korean National Sample Cohort Study The reductions in life expectancy were steeper in younger adults, meaning a 40-year-old with both conditions loses more remaining years than a 70-year-old with the same combination.
Mental health also shifts the curve in ways cardiologists are only beginning to integrate into care. A meta-analysis spanning 25 years of research found that depression after a heart attack roughly doubled the risk of dying from any cause and nearly tripled the risk of dying specifically from a cardiac cause.25PubMed. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research Depression is not just an emotional response to bad news; it appears to interact with the biology of heart disease through inflammation, stress hormones, and poor adherence to medications and lifestyle changes. Screening for and treating depression after a cardiac event is not a luxury; it is part of survival.
Sex Differences in Living With Heart Disease
Women develop heart disease later than men, on average about three years later for general heart disease and more than four years later for heart attacks, according to U.S. data. Despite this later onset, women actually spend more years living with heart disease: roughly 7.9 years at age 50 compared with 6.7 for men.26PubMed Central. Life with and without health disease among women and men over 50 This partly reflects women’s longer overall life expectancy, but it also means that heart disease is a larger share of many women’s later years than they might expect.
When it comes to heart failure specifically, a large European study found that after adjusting for the age gap, male sex was independently associated with about a 25% higher risk of death.27European Heart Journal. Female sex is associated with a better long-term survival in patients hospitalized with congestive heart failure The reasons are not entirely clear but may relate to the types of heart failure men and women tend to develop, differences in preserved heart function, and patterns of treatment.
Income, Education, and Neighborhood Effects
Where you live and what you earn turn out to be surprisingly strong predictors of how long you survive with heart disease. Four measures consistently linked to worse cardiovascular outcomes in wealthy countries are income level, education, employment status, and neighborhood-level deprivation.28PubMed Central. Socioeconomic Status and Cardiovascular Outcomes: Challenges and Interventions These are not just proxies for access to doctors. They track with stress exposure, dietary quality, physical activity, smoking rates, and the likelihood of participating in cardiac rehabilitation.
In heart failure patients with reduced pumping function, low income was associated with about a 52% higher mortality risk and a 45% higher readmission risk. Low education tracked similarly, with about a 27% higher death rate and a 62% higher readmission rate.29PubMed Central. Impact of Socioeconomic Status on Mortality and Readmission in Patients With Heart Failure With Reduced Ejection Fraction: The ARIC Study Living in a highly deprived neighborhood independently raised the risk of being readmitted to the hospital.30PubMed Central. Impact of Socioeconomic Status on Heart Failure These disparities mean that two people with identical heart conditions can face very different timelines depending on economic circumstances.
Decades of Progress, Stalling in Recent Years
The bigger picture is encouraging, at least historically. Heart disease mortality has been falling for five decades.31PubMed Central. Heart Disease Mortality in the United States, 1970 to 2022 Since the late 1970s, age-adjusted death rates from coronary heart disease and stroke in industrialized countries dropped to roughly a third of their 1960s peak by 2000, making it arguably the greatest public health success story of the second half of the twentieth century.32PubMed Central. Decline in Cardiovascular Mortality: Possible Causes and Implications
Heart failure survival has improved alongside these broader trends. In the United Kingdom, one-year survival after a heart failure diagnosis rose from about 74% in 2000 to 81% in 2016. Five-year survival climbed from about 41% to 48%, and ten-year survival from about 20% to 26%.33PubMed. Trends in survival after a diagnosis of heart failure in the United Kingdom 2000-2017: population based cohort study Those gains came from a combination of better medications, wider use of devices, more aggressive revascularization, and improved chronic disease management. Some researchers have noted, however, that the pace of decline in heart disease mortality has slowed or plateaued in recent years, partly driven by rising obesity and diabetes rates offsetting treatment advances.
Growing Up and Older With Congenital Heart Disease
A category that often gets left out of this conversation is congenital heart disease, the structural defects people are born with. Advances in pediatric surgery have made survival to adulthood the expected outcome for most congenital heart conditions.34International Journal of Cardiology Congenital Heart Disease. Predicting 10-year mortality in adults with congenital heart disease But surviving to adulthood is not the same as having a normal life expectancy, and this is a point where patients and their doctors often disagree. In a study of adults 40 to 53 years after their congenital heart surgery, about two-thirds of patients believed their life expectancy was normal. Their cardiologists thought so for fewer than half.35PubMed Central. Life expectancy and end-of-life communication in adult patients with congenital heart disease, 40–53 years after surgery That gap matters because it affects how aggressively patients plan for follow-up care, advance directives, and long-term health management. Many adults with repaired congenital heart disease develop new complications like arrhythmias, valve deterioration, or heart failure decades later, and staying in regular contact with a specialized cardiologist is one of the clearest ways to catch those problems before they become life-threatening.